Astatine-211-Labeled Radiotherapeutics An Emerging Approach to Targeted Alpha-Particle Radiotherapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|6|14|1433-1455

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.6, Iss.14, 2000-09, pp. : 1433-1455

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Applications of 211At and 223Ra in Targeted Alpha-Particle Radiotherapy

By  

Current Radiopharmaceuticals, Vol. 4, Iss. 4, 2011-10 ,pp. : 283-294

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Alpha-Particle Therapy with 227Th-Labeled Antibodies

By  

Current Radiopharmaceuticals, Vol. 1, Iss. 3, 2008-09 ,pp. : 209-214

Bentham Science Publishers

Access to resources Recommend Favorite

Actinium-225 in Targeted Alpha-Particle Therapeutic Applications

By  

Current Radiopharmaceuticals, Vol. 4, Iss. 4, 2011-10 ,pp. : 306-320

Bentham Science Publishers

Access to resources Recommend Favorite

[211At]Astatine-Labeled Compound Stability: Issues with Released [211At]Astatide and Development of Labeling Reagents to Increase Stability

By  

Current Radiopharmaceuticals, Vol. 1, Iss. 3, 2008-09 ,pp. : 144-176

Bentham Science Publishers

Access to resources Recommend Favorite

Astatine-211: Production and Availability

By  

Current Radiopharmaceuticals, Vol. 4, Iss. 3, 2011-07 ,pp. : 177-185

Bentham Science Publishers

Access to resources Recommend Favorite